In order to mirror more closely in vivo gene therapy of malignant brain tumors, experiments are underway to insert the HSV-TK-Luc fusion gene (and an improved version of it) into appropriate viral vectors and subsequently use them for treatment of orthotopically established gliomas in mice. Here, TKT is linked to central nervous system cancer.